Relmada Therapeutics Inc (RLMD)

0.3614 -0.02 (-4.79%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Relmada Therapeutics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Eli Lilly and Co Upgrade
Sensei Biotherapeutics Inc --
NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc --
iBio Inc --